中国北京自愿两剂水痘疫苗时代高度接种学校人群中的水痘暴发
2015年3月29日至5月17日,北京一所小学1056名学生中发生20例水痘,总罹患率2.0%,其中95%为突破性病例。两剂疫苗接种者突破性水痘占2.0%(13/649),一剂占1.6%(6/362),未接种占14.3%(1/7)。结论认为中等两剂疫苗覆盖率不足以预防暴发。
要点
- 两剂水痘疫苗覆盖率63.2%的学校发生20例水痘,总罹患率2.0%。
- 突破性病例占95%(19/20),两剂接种者罹患率2.0%(13/649)。
- 两剂接种者发生突破性水痘仍具传染性,指示病例未隔离。
核心结论
- 中等两剂水痘疫苗覆盖率不足以预防水痘暴发。
- 两剂接种者发生突破性水痘仍具传染性。
- 两剂时代预防水痘暴发可能需要高两剂疫苗覆盖率和及时隔离病例。
研究设计与样本
- 队列研究,于2015年3月29日至5月17日在一所小学开展。
- 水痘病例定义为该校学生出现无其他明显原因的全身性斑丘疱疹急性发作。
- 突破性水痘定义为接种1剂或2剂水痘疫苗者末次接种后超过42天发生水痘。
- 疫苗接种信息来自免疫记录,既往水痘史和临床表现通过调查学生父母收集。
主要发现
- 全校1056名学生中1027名(97.3%)报告无既往水痘史。
- 暴发前98.6%学生至少接种1剂水痘疫苗,多数(63.2%)接种两剂。
- 共识别20例水痘病例,总罹患率2.0%。
- 半数病例发生在指示病例所在班级,指示病例为两剂接种者且症状出现后未隔离。
- 突破性水痘占95%(19/20),未接种、一剂和两剂接种学生的罹患率分别为14.3%(1/7)、1.6%(6/362)和2.0%(13/649)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Two-dose varicella vaccination has been available in Beijing since 2012 in the private sector. We investigated a varicella outbreak in a highly vaccinated elementary school population. METHODS: A cohort study was carried out and a varicella case was defined as an acute onset of generalized maculopapulovesicular rash without other apparent cause in a student attending the school from March 29 through May 17, 2015. Breakthrough varicella was defined as varicella >42days after the last vaccine dose among both 1- or 2-dose varicella vaccine recipients. Vaccination information was collected from immunization records; information on prior varicella and clinical presentations was collected by surveying students' parents. RESULTS: Of the 1056 students in the school, 1027 (97.3%) reported no history of varicella. Prior to the outbreak, 98.6% of students had received ≥1 dose of varicella vaccine, and most (63.2%) students received two doses. Twenty varicella cases were identified for an overall attack rate of 2.0%. Half of the cases occurred in the classroom of the index case-patient, a two-dose recipient who was not isolated after symptom onset. Breakthrough varicella accounted for 95% of cases (19/20) with attack rates of 14.3% (1/7), 1.6% (6/362) and 2.0% (13/649) among unvaccinated, one-dose, and two-dose students, respectively. Most case-patients (18/20, 90%) had <50 lesions. No difference in clinical presentations was found between one-dose and two-dose recipients with breakthrough varicella. CONCLUSION: Moderate two-dose varicella vaccine coverage was insufficient to prevent a varicella outbreak. Two-dose recipients with breakthrough varicella are contagious. High two-dose varicella vaccine coverage and timely isolation of cases may be needed for varicella outbreak prevention in the two-dose era.
引用
- Suo L, Lu L, Wang Q, et al. Varicella outbreak in a highly-vaccinated school population in Beijing, China during the voluntary two-dose era. Vaccine. 2017. PMID: 28684165. doi:10.1016/j.vaccine.2017.06.065
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。